Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes Care"
DOI: 10.2337/dc18-2648
Abstract: OBJECTIVE To explore the efficacy, safety, and tolerability of once-weekly efpeglenatide, a long-acting glucagon-like peptide 1 receptor agonist (GLP-1 RA), in early type 2 diabetes (T2D) (drug naive or on metformin monotherapy). RESEARCH DESIGN AND… read more here.
Keywords: efpeglenatide; weekly efpeglenatide; type diabetes; placebo ... See more keywords